Nothing new today. The sweep found no new psychiatric drug approvals, safety communications, recalls or guideline releases. The only regulatory item was a supplemental approval dated 10 August for a generic olanzapine application — an administrative change to an already marketed product, with no implication for prescribing.
A quiet regulatory day is worth reporting as quiet rather than filled. The substantive material for this desk today is in the cohort and trial evidence above, and two of those items carry more practical weight than most regulatory notices would: the finding that physical multimorbidity diverges from the early twenties, and the evidence that rapid relapse after antipsychotic discontinuation reflects illness severity rather than a withdrawal phenomenon.
If you want one thing to act on from the regulatory angle, it is the standing one rather than a new one: check that the metabolic monitoring schedule attached to every antipsychotic you prescribe is actually being followed, because that requirement predates all of today's evidence and is the most commonly unmet standard in the specialty.
- No new psychiatric approvals, safety communications, recalls or guidelines today.
- The only item was a supplemental approval for a generic olanzapine application; no prescribing change.
- Use the quiet day to audit metabolic monitoring compliance against your existing standard.
- Check baseline weight, glucose and lipids are recorded before any new antipsychotic is started.
- Confirm the three-month post-initiation review is happening, not just the annual one.
The statistics, in plain English
A supplemental approval to a generic application is a regulatory and manufacturing event, not a clinical one: the molecule, the evidence and the labelling are unchanged. It typically reflects a change in manufacturing site, formulation detail or packaging. Nothing in it constitutes new safety or efficacy information, which is why it is reported here as a null rather than as news.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for psychiatry, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free